stock & financial message boards
  Login  |  Register |  Site Map  |  Blogs |  Recent Activity  |  Members  | Glossary
Ticker/Industry
  Joined Today: 1

ISPH Inspire Pharmaceuticals, Stock Message Board

All Messages

ISPH Message Board Home | Join The ISPH Group | 

Page [3 of 4] < Prev
|1|2|3|4
|Next >
#16: ISPH News Inspire Terminates Phase 2 Clinical Trial for Platelet Aggregation Inhibitor
Stock News Bot
August 7, 2006 02:40:00 PM
DURHAM, N.C.--(BUSINESS WIRE)--Aug. 7, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that it has terminated its Phase 2 clinical trial of INS50589 Antiplatelet, based on the...
view message
ignore post
recommend post
#15: ISPH News Inspire Announces Vice President Appointments
Stock News Bot
August 7, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Aug. 7, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the hiring of two new Vice Presidents, Bart J. Dunn as Vice President, Business Development...
view message
ignore post
recommend post
#14: ISPH News Inspire Announces Webcast of Presentation at Bank of America Specialty Pharmaceuticals Conference
Stock News Bot
August 4, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Aug. 4, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO, and Michael R. Knowles, M.D., Professor...
view message
ignore post
recommend post
#13: ISPH News Inspire Initiates Phase 3 Clinical Trial of Denufosol Tetrasodium in Cystic Fibrosis Patients
Stock News Bot
July 27, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 27, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the initiation of a Phase 3 clinical trial to evaluate its drug candidate, denufosol...
view message
ignore post
recommend post
#12: ISPH News Inspire Announces Date for Conference Call and Webcast to Discuss Second Quarter 2006 Financial Results
Stock News Bot
July 25, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 25, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that it plans to report second quarter 2006 financial results on Tuesday, August 8, 2006...
view message
ignore post
recommend post
#11: ISPH News Inspire Announces Webcast of Presentation At C.E. Unterberg, Towbin Emerging Growth Conference
Stock News Bot
July 5, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 5, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Thomas R. Staab, II, CFO and Treasurer, will present at the C.E. Unterberg, Towbin...
view message
ignore post
recommend post
#10: ISPH News Inspire Announces Receipt of FDA Approvable Letter for Diquafosol
Stock News Bot
December 2, 2005 01:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Dec. 2, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that the U.S. Food and Drug Administration (FDA) has issued a second approvable letter for...
view message
ignore post
recommend post
#9: ISPH News Inspire Reports Third Quarter 2005 Financial Results; Third Quarter 2005 Revenue Up 73%, Company Raises 2005 Revenue Guidance
Stock News Bot
November 8, 2005 01:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Nov. 8, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today reported financial results for the third quarter ended September 30, 2005. Total revenue for the...
view message
ignore post
recommend post
#8: ISPH News Inspire Announces Date for Conference Call and Webcast to Discuss Third Quarter 2005 Financial Results
Stock News Bot
October 25, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Oct. 25, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) today announced that it plans to report third quarter 2005 financial results on Tuesday, November 8, before...
view message
ignore post
recommend post
#7: ISPH News Inspire Provides Update on Cystic Fibrosis Program; Moving Forward to Request End-of-Phase 2 Meeting with FDA
Stock News Bot
October 13, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Oct. 13, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) today announced that three studies in its cystic fibrosis (CF) program, including two six-month animal...
view message
ignore post
recommend post
#6: ISPH News Inspire to Present at UBS Global Life Sciences Conference
Stock News Bot
September 21, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Sept. 21, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and Chief Executive Officer, will present at...
view message
ignore post
recommend post
#5: ISPH News Inspire Announces SEC Investigation
Stock News Bot
September 7, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Sept. 7, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that the U.S. Securities and Exchange Commission (SEC) is conducting a formal, nonpublic...
view message
ignore post
recommend post
#4: ISPH News Inspire Reports Second Quarter 2005 Financial Results; Second Quarter 2005 Revenue More Than Triple Second Quarter 2004; Company Raises 2005 Guidance
Stock News Bot
August 9, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Aug. 9, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today reported financial results for the second quarter ended June 30, 2005. Total revenue for the second...
view message
ignore post
recommend post
#3: ISPH News Inspire Announces Date for Conference Call and Webcast to Discuss Second Quarter 2005 Financial Results
Stock News Bot
July 26, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 26, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) today announced that it will report second quarter 2005 financial results on Tuesday, August 9, before the...
view message
ignore post
recommend post
#2: ISPH News Inspire Adds Lynn Smiley, M.D. as Chief Medical Officer
Stock News Bot
July 21, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 21, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today the hiring of M. Lynn Smiley, M.D. for the newly created position of Chief Medical Officer....
view message
ignore post
recommend post
Page [3 of 4] < Prev
|1|2|3|4
|Next >

Group Home | Login if you want to post a message